Jushi (JUSHF) Stock Price, News & Analysis

Company Overview

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

Key Stats

• Today's Range: $0.33 to $0.36
• 50-Day Range: $0.25 to $0.44
• 52-Week Range: $0.22 to $0.78
• Volume: 76,443 shs
• Average Volume: 226,832 shs
• Market Capitalization: $69.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Jushi Stock Analysis - MarketRank™

Jushi scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Jushi.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Jushi are expected to grow in the coming year, from ($0.23) to ($0.17) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Jushi is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Jushi is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.49% of the float of Jushi has been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Jushi has recently decreased by 38.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Jushi does not currently pay a dividend.

Dividend Growth

Jushi does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.49% of the float of Jushi has been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Jushi has recently decreased by 38.16%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: -0.30

News Sentiment

Jushi has a news sentiment score of -0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Jushi this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Jushi insiders have not sold or bought any company stock.

Percentage Held by Insiders

21.66% of the stock of Jushi is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 21.68% of the stock of Jushi is held by institutions.

JUSHF Stock Analysis - Frequently Asked Questions

How have JUSHF shares performed this year?

Jushi's stock was trading at $0.3110 at the start of the year. Since then, JUSHF stock has increased by 13.8% and is now trading at $0.3540.
View the best growth stocks for 2025 here.

How were Jushi's earnings last quarter?

Jushi Holdings Inc. (OTCMKTS:JUSHF) issued its earnings results on Thursday, May, 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.06) by $0.03. The company had revenue of $63.85 million for the quarter, compared to the consensus estimate of $66.23 million.

How do I buy shares of Jushi?

Shares of JUSHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/08/2025
• Today: 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:JUSHF
• CIK: 1909747
• Web: www.jushico.com
• Phone: 561-617-9100
• Fax: N/A
• Employees: 1,188
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-65,100,000.00
• Net Margins: -20.93%
• Pretax Margin: -8.16%
• Return on Equity: N/A
• Return on Assets: -10.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.17
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $269.45 million
• Price / Sales: 0.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -8.85

Miscellaneous

• Outstanding Shares: 196,632,000
• Free Float: 154,042,000
• Market Cap: $69.61 million
• Optionable: Not Optionable
• Beta: -0.86